Cara Therapeutics | CARA - Revenu Net





Revenu Net Changement Date
Acadia Pharmaceuticals USD 53.52M 22.02M 2026-09
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
Cara Therapeutics USD -6.8M 1.28M 2026-03
Cassava Sciences USD -8.6M 1.73M 2026-06
Chugai Pharma JPY 143.55B 27.22B 2026-09
Cipla INR 8.78B 884.9M 2026-09
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -7.01M 663K 2026-06
CSL USD 401M 96.5M 2025-12
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD 247.05M 17.14M 2026-09
J&J USD 210M 5.32B 2026-09
Neurocrine Biosciences USD 206.5M 62.1M 2026-09
Pacira USD 325.3M 320.65M 2026-09
Pfizer USD 3.24B 3.49B 2026-09
RedHill Biopharma USD -1.54M 0 2024-06
Supernus Pharmaceuticals USD -58.37M 56.08M 2026-06
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12